BlueCrest Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,785
| Closed | -$472K | – | 595 |
|
|
2019
Q3 | $472K | Buy |
+2,785
| New | +$472K | 0.03% | 265 |
|
|
2018
Q4 | – | Sell |
-1,836
| Closed | -$354K | – | 1423 |
|
|
2018
Q3 | $354K | Sell |
1,836
-5,662
| -76% | -$1.09M | 0.01% | 929 |
|
|
2018
Q2 | $1.27M | Buy |
+7,498
| New | +$1.27M | 0.03% | 419 |
|
|
2018
Q1 | – | Sell |
-63,000
| Closed | -$9.44M | – | 1622 |
|
|
2017
Q4 | $9.44M | Buy |
+63,000
| New | +$9.44M | 0.26% | 74 |
|
|
2017
Q2 | – | Sell |
-3,231
| Closed | -$353K | – | 1092 |
|
|
2017
Q1 | $353K | Buy |
+3,231
| New | +$353K | 0.02% | 479 |
|
|
2016
Q1 | – | Sell |
-3,851
| Closed | -$485K | – | 1062 |
|
|
2015
Q4 | $485K | Buy |
3,851
+1,618
| +72% | +$204K | 0.02% | 562 |
|
|
2015
Q3 | $233K | Buy |
+2,233
| New | +$233K | 0.01% | 684 |
|